U.S. market Open. Closes in 6 hours 3 minutes

CRDL | Cardiol Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A78.76KN/AN/AN/A
Cost of Revenue248.35K219.91KN/A229.54K150.57KN/A
Gross Profit-248.35K-219.91K78.76K-229.54K-150.57KN/A
Operating Expenses29.79M41.34M38.74M20.69M14.13M7.49M
Selling, General & Admin15.56M22.37M27.87M9.95M10.45M5.87M
Research & Development14.22M18.96M10.87M10.52M3.53M1.53M
Other Operating Expenses0164.44K112.23K7.40K298.80KN/A
Operating Income-29.79M-50.34M-45.47M-20.61M-13.58M-7.39M
Other Expenses / Income1.66M9.17M6.92M-27.06K198.94K-7.84M
Before Tax Income-28.13M-30.93M-31.64M-20.64M-13.68M-15.89M
Income Tax Expenses5.00-10.24M-6.91M7.40K299.42K663.37K
Net Income-28.13M-30.93M-31.64M-20.64M-13.68M-15.89M
Interest ExpensesN/AN/AN/AN/A621.00663.37K
Basic Shares Outstanding64.46M62.51M43.22M29.86M25.82M15.37M
Diluted Shares Outstanding64.46M62.51M43.22M29.86M25.82M15.37M
EBITDA-29.59M-50.12M-45.25M-20.38M-13.43M-7.30M
EBITDA Margin0.00%0.00%-57,456.46%0.00%0.00%0.00%
EBIT-28.13M-41.17M-38.55M-20.63M-13.38M-14.57M
EBIT Margin0.00%0.00%-48,949.43%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙